Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-941-3 | CAS number: 717-74-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Apr 22 to Jul 16, 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
- Version / remarks:
- Version not specified
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- 1,3,5-triisopropylbenzene
- EC Number:
- 211-941-3
- EC Name:
- 1,3,5-triisopropylbenzene
- Cas Number:
- 717-74-8
- Molecular formula:
- C15H24
- IUPAC Name:
- 1,3,5-tris(propan-2-yl)benzene
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Eastman Chemical Company, Batch No. 6F11027000
- Expiration date of the lot/batch: 17/11/2016
- Purity: 96%
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (Barcelona, Spain)
- Females nulliparous and non-pregnant: Yes
- Age at study initiation: 8 wks
- Weight at study initiation: males: ca. 286 - 278 g; females: ca. 212 - 238 g
- Housing: Bedding material: Capsumlab Lecho_10 (autoclavable)
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 8 days (Acclimatisation to the nose-only restraining tubes was performed for 35 minutes immediately before the exposure)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 16.4-23.7ºC
- Humidity (%): 21-52%
- Photoperiod (hrs dark / hrs light): 12:12, 07.00 to 19.00 CET
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Mass median aerodynamic diameter (MMAD):
- 1.7 µm
- Remark on MMAD/GSD:
- Geometric Standard Deviation (GSD) on the two PSD determinations (PSD #1 and PSD #2) were 4.3 and 5.4 respectively, which are above the target range (1.5 to 3). Single outliers during weighing may have contributed to these high values. Nevertheless, these values were considered to be acceptable taking into account that more than 89% and 67% of particles were below upper limit of 4µm in PSD #1 and PSD #2 respectively. Hence, the particle size distributions obtained were considered to be respirable to rats and these incidents are considered to have no impact on the quality / integrity of the study.
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: flow-past, nose-only; Exposure chambers type EC-FPC-232 (anodised aluminium) equipped with glass exposure tubes
- Exposure chamber volume: 3L
- Method of holding animals in test chamber: restraint tubes which were positioned radially around the exposure chamber
- Source and rate of air: filtered air from a compressor; 0.5-1.0 L/min through each inhalation tube
- System of generating particulates/aerosols: Nebulizer
- Method of particle size determination: Mean Mass Median Aerodynamic Diameter (MMAD) of particle size distribution during exposure was calculated from two gravimetric measurements
- Temperature, humidity, pressure in air chamber: temperature and relative humidity of the test atmosphere in the exposure chamber was maintained as required by experimental conditions. Air flow was monitored regularly.
TEST ATMOSPHERE
- Brief description of analytical method used:
1. The test item usage determined once per exposure by weighing the amount of the test item before/after exposure to determine the quantity of test item used;
2. Aerosol concentration was determined by gravimetric analysis at least once during each hour of exposure. Test aerosol samples were collected onto a Whatman filter (grade F319-04) using a filter sampling device;
3. Particle size distribution was determined gravimetrically twice during exposure;
4. Temperature and relative humidity in the chamber was measured continuously during exposure; and
5. Actual air flow rate monitored hourly in each group during exposure.
- Samples taken from breathing zone: Not specified; but the exposure system ensured a uniform distribution
CLASS METHOD (if applicable)
- Rationale for the selection of the starting concentration: Several tests were performed to establish the highest stable aerosol concentration achievable that could be maintained at least for 4 hours. Aerosol starting dose of 5 mg/L air was selected as no toxic effects were expected based on the available data. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- ca. 4 h
- Remarks on duration:
- 4 consecutive hours
- Concentrations:
- mean concentration of 5.0 mg/L air during 4 hours
- No. of animals per sex per dose:
- 3 males and 3 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Examined daily for mortality and morbidity. Clinical observations made hourly during exposure and immediately and 1hr following exposure then once daily thereafter for remainder of observation period. Weights were taken just before the start of the inhalation period, daily from days 2 to 5, then on days 8, 10, 11 and immediately before sacrifice on day 15 of study.
- Necropsy of survivors performed: Yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: clinical signs, body weight, post-mortem gross necropsy of abdominal and thoracic cavities and contents. Special attention paid to any change in respiratory tract
Results and discussion
Effect levels
- Key result
- Sex:
- not specified
- Dose descriptor:
- LC50
- Effect level:
- > 5 mg/L air (nominal)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- All animals survived the scheduled observation period.
- Clinical signs:
- other: Transient clinical signs of toxicity (reduced mobility, absence of turning reflex, weakness, respiratory crackles)
- Body weight:
- Body weight stagnation in both sexes, but with a longer duration in females
- Gross pathology:
- No macroscopic findings were observed during necropsy.
- Other findings:
- Dirty fur was observed in all animals 1 hour after exposure. In addition, chromodacryorrhea (1 out of 3 males) and mild piloerection (1 out o 3 males and 2 out of 3 females) were recorded 1 hour after exposure. Chromodacryorrhea was not longer observed from day 2 of study onwards but dirty fur (all females) and mild piloerection (1 out o 3 males and 2 out of 3 females) were still present at day 2 of study. These clinical signs were not longer present at day 3 of study
Any other information on results incl. tables
3 deviations from the study plan were reported:
(1) Geometric Standard Deviation (GSD) on the two PSD determinations (PSD #1 and PSD #2) were 4.3 and 5.4 respectively, which are above the target range (1.5 to 3). Single outliers during weighing may have contributed to these high values. These values were considered to be acceptable taking into account that more than 89% and 67% of particles were below upper limit of 4µm in PSD #1 and PSD #2 respectively. These incidents are considered to have no impact on the quality / integrity of the study.
(2) Relative humidity and temperature in the husbandry room were sporadically below the optimal ranges during the study. This incident is considered not to have any impact on the quality/integrity of the study, since the relative humidity and temperature decreases were minor and no related clinical signs were recorded due to this incident.
(3) Coefficient of variation (%CV) in the high level of the exposure chamber was 6.17 %, which is slightly above the acceptance criteria (5%). Nevertheless, this incident is considered not to have an impact on the quality / integrity of the study, since all air flow values were in the range of 0.8-1.0 L/min which is within the airflow range required for inhalation studies to guarantee sufficient air flow supply to the animals during the exposure (0.5-1.0 L/min).
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- according to EC 1278/2008 as amended
- Conclusions:
- LC50 of 1,3,5-Triisopropylbenzene was greater than 5.0 mg/L air (gravimetrically determined mean aerosol concentration).
- Executive summary:
The acute inhalation toxicity of 1,3,5-triisopropylbenzene was tested according to the acute toxic class method with Sprague-Dawley rats according to OECD TG 436. Treatment of animals with 1,3,5-triisopropylbenzene aerosol resulted in no deaths. However, a toxic effect was observed. This toxic effect was characterized by transient clinical signs of toxicity (reduced mobility, absence of turning reflex, weakness, respiratory crackles) and body weight stagnation in both sexes, but with a longer duration in females.
It was concluded that, under the experimental conditions:
LC50 of 1,3,5-Triisopropylbenzene was greater than 5.0 mg/L air (gravimetrically determined mean aerosol concentration).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.